Both in Pharmaceuticals
Alnylam Pharmaceuticals vs Viatris
Over the past year ALNY returned −62.5% and VTRS returned +80.3%; their daily moves had a correlation of 0.13.
ALNY −62.5% VTRS +80.3%Growth of $1, one year, split-adjusted
| Metric | ALNY | VTRS |
|---|---|---|
| Price | $162.76 | $18.99 |
| Market cap | $21.80B | $21.81B |
| Today | +1.79% | +0.34% |
| 1 month | −27.3% | +8.2% |
| 6 months | −46.3% | +19.0% |
| Year to date | −59.1% | +52.5% |
| 1 year | −62.5% | +80.3% |
| Revenue growth (YoY) | +16.7% | +4.9% |
| Gross margin | 75.2% | 38.8% |
| Net margin | 148.6% | −3.2% |
| P/E (TTM) | 8.0× | — |
| Price / sales | 4.3× | 1.5× |
| Net cash | $2.57B | -$12.46B |
| Dividend yield | — | 2.53% |
| Volatility (60d) | 72.9% | 23.2% |
| Short % of float | 4.9% | 3.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).